Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
14.91
-0.09 (-0.60%)
Aug 15, 2025, 10:30 AM - Market open

Oruka Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024
Period Ending
Jun '25 Dec '24
Cash & Equivalents
65.461.58
Short-Term Investments
263.01314.07
Cash & Short-Term Investments
328.41375.65
Prepaid Expenses
3.611.22
Total Current Assets
332.01376.87
Property, Plant & Equipment
2.251.04
Long-Term Investments
23.0518.07
Other Long-Term Assets
0.10.04
Total Assets
357.42396.02
Accounts Payable
4.663.46
Accrued Expenses
3.79.37
Current Portion of Leases
0.660.21
Total Current Liabilities
12.1113.04
Long-Term Leases
1.670.76
Total Liabilities
13.7813.8
Common Stock
0.040.04
Additional Paid-In Capital
470463.02
Retained Earnings
-129.3-83.72
Comprehensive Income & Other
-0.03-0.04
Total Common Equity
340.71379.29
Shareholders' Equity
343.64382.22
Total Liabilities & Equity
357.42396.02
Total Debt
2.330.97
Net Cash (Debt)
349.13392.75
Net Cash Per Share
9.6623.39
Filing Date Shares Outstanding
37.4537.44
Total Common Shares Outstanding
37.4537.44
Working Capital
319.9363.83
Book Value Per Share
9.1010.13
Tangible Book Value
340.71379.29
Tangible Book Value Per Share
9.1010.13
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q